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Objective: To investigate whether endothelial mono-
layer permeability changes induced by inflammatory
mediators are affected by the extracellular matrix
protein used for cell seeding.
Methods: Human umbilical venular endothelial cells
(HUVEC) were grown to confluent monolayers on
membranes coated with either collagen, fibronectin
or gelatin. The permeability to albumin and dextran
was then assessed, both under normal conditions and
after treatment with tumor necrosis factor-alpha
(TNF- a ) and bacterial lipopolysaccharide (LPS).
Results: With any of the three protein coatings, tight
junctions were formed all over the monolayers. The
permeability of the coated membranes to albumin
and dextran was reduced strongly by confluent
monolayers; the relative reduction was similar for the
three matrix proteins used. Pre-incubation of the
monolayers with either TNF- a or LPS increased
permeability dose dependently. However, the relative
increase due to either treatment was independent of
the protein used for membrane coating.
Conclusion: The extracellular matrix protein used for
initial seeding of endothelial cultures plays a minor
role in determining the permeability changes induced
in HUVEC monolayers by inflammatory mediators.
Key words: Endothelium, Extracellular matrix (ECM),
HUVEC, Inflammatory mediator, Tumor necrosis factor,
endotoxin, monolayer permeability
Introduction
The vascular endothelium acts as a dynamic barrier
that selectively restricts the passage of plasma and
cells from the blood into the adjacent tissues. Local
and reversible alterations of barrier function typically
occur as part of the immune response during which
inflammatory mediators cause a transient increase of
vascular permeability resulting in the formation of
tissue oedema. However, during systemic inflamma-
tory response syndrome (SIRS),1 over-production of
inflammatory mediators may irreversibly damage
vascular integrity and cause excessive loss of fluid
from the circulation. This hazardous event may lead to
prolonged tissue hypoperfusion, organ dysfunction
and death.2 Therefore, prevention of vascular damage
could contribute to improved survival of patients
suffering from SIRS.3,4 Many have studied the role of
the endothelium in vascular permeability using in
vitro models of endothelial monolayers cultured on
semi-permeable supports.5 –7 Multiple mechanisms
may be involved in increased endothelial permeabil-
ity, such as cell contraction and retraction,8 enhanced
transcellular vesicle transport,9 disruption of inter-
cellular junctions10 and apoptosis.11
Recently, it has been suggested that endothelial
permeability may also depend on the composition
and structure of the underlying extracellular matrix
(ECM).12 For example, it has been shown that
fibronectin significantly contributes to endothelial
monolayer permeability by providing attachment sites
for ECM proteins and endothelial cells.13 When
monolayers cultured on fibronectin were treated with
tumor necrosis factor-a (TNF-a), a permeability
increase was observed which was accompanied by a
loss of fibronectin from the ECM.14 TNF-a also affects
the expression of other matrix receptors on endothe-
lial cells, confirming a role for endothelial – ECM
contacts in vascular permeability.15 Furthermore,
stimulation of endothelial cells with TNF-a induced
the expression of a 96-kDa matrix metalloprotei-
nase,16 suggesting that matrix degradation may be
involved in increased permeability.17
For the purpose of studying endothelial permeabil-
ity in vitro, these findings seem to imply that
endothelial cells should be cultured on (a mixture of)
ECM proteins, preferably containing fibronectin, but
other ECM coatings like gelatin and different types of
collagen are used frequently.18 It remains unclear
whether different coatings eventually result in differ-
ent monolayer permeability changes under the influ-
ence of inflammatory mediators. A comparison of in
vitro studies on endothelial permeability is hampered
by the many differences in the origin and species of
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the endothelial cells and, particularly, by the differ-
ences in the design of the monolayer system, includ-
ing the matrix used for cell seeding.
Therefore, we have compared the permeability
characteristics of human umbilical venular endothe-
lial cells (HUVEC) seeded on membranes coated
with either collagen, fibronectin or gelatin. For this
purpose, we have selected a suitable in vitro model
that supports the attachment and growth of HUVEC,
and allows restricted diffusion of macromolecules,
visual examination by both bright field microscopy
and ultramicroscopy, and easy and simultaneous
permeability determinations. The inflammatory
mediators TNF-a and bacterial lipopolysaccharide
(LPS), which are involved in the onset of SIRS, have
been shown to enhance endothelial permeability
both in vivo and in vitro.19 –22 We measured the
permeability for both albumin and dextran in untrea-
ted HUVEC monolayers and in cultures after treat-
ment with either TNF-a or LPS.
Materials and methods
Materials
Culture medium M199, supplemented with 25 mmol/l
HEPES, Earl’s salts and L-glutamine, as well as heat-
inactivated newborn calf serum (NCS), penicillin-
streptomycin and trypsin/EDTA were obtained from
Life Technologies (Paisley, Scotland). Normal human
serum was supplied by a local transfusion service. A
pool of serum of at least five donors was first heat
inactivated (30 min at 56°C), and stored at –20°C
before use. Transwell-well culture inserts, tissue cul-
ture plates and flasks were all from Costar (Cam-
bridge, MA). Fluorescin-labelled bovine serum albu-
min (FITC-BSA), rhodamin-labelled dextran
(RITC-DEX, mean molecular weight 70,000), col-
lagenase type I (from Clostridium hystolyticum), pig
skin gelatin (type A) and LPS (E. coli, strain 055:B5)
were purchased from Sigma Chemical (St Louis, MO).
Human fibronectin was obtained from Boehringer
Mannheim (Mannheim, Germany). A crude fraction of
endothelial cell growth factors (ECGF) was kindly
provided by the Department of Pediatrics, University
Hospital of Nijmegen, The Netherlands. Heparin was
obtained from Leo pharmaceutical products (Weesp,
The Netherlands). Recombinant human TNF-a (6 ´
107 U/mg, endotoxin content < 1 EU/mg) was
obtained from Bender & Co, Vienna.
Isolation and culture of HUVEC
Endothelial cells were isolated according to a mod-
ification of the method described by Jaffe and co-
workers.23 Upon delivery the umbilical cords were
placed in sterile, ice cold cord buffer (140 mmol/l
NaCl, 4 mmol/l KCl, 11 mmol/l D-glucose, 10 mmol/l
HEPES, 100 IU penicillin, and 0,1 mg/ml streptomy-
cin, pH 7,3) and stored at 4°C until use. In brief, the
umbilical vein was rinsed with cord buffer to remove
blood and debris from the lumen after which the vein
was filled with medium M199 containing 0.1% (w/v)
collagenase. Endothelial cells were detached by incu-
bation for 20 min at 37°C and harvested by collecting
the collagenase solution. After centrifugation (5 min at
300 ´ g), the cells were resuspended in complete
medium (M199 with 10% NCS, 10% normal human
serum, 50 U/ml penicillin, 50mg/ml streptomycin,
150mg/ml crude ECGF and 5 U/ml heparin) and
seeded onto 0.1% gelatin-coated 25 cm2 culture flasks.
The cultures were kept in a humidified incubator at
37°C under a 5% CO2/95% air atmosphere. After one
day, and then three times weekly, the culture medium
was refreshed. Confluent cultures (typically yielding
105 cells/cm2 or more) were passaged by detaching
the cells with 0.5 mg/ml trypsin and 0.2 mg/ml EDTA,
which was followed by centrifugation and resuspen-
sion in complete medium. For appropriate growth, a
split ratio of 1:2 or 1:3 was used. All experiments
were performed on cells that had been passaged less
than four times.
Endothelial origin of the cultures was confirmed by
phase contrast microscopy, which revealed confluent
cultures displaying a typical cobblestone morphology,
while immunocytochemical analysis revealed positive
staining for von Willebrand Factor and CD31 (platelet
endothelial cell adhesion molecule (PECAM)-1). Activa-
tion with TNF-a or LPS-induced expression of inter-
cellular adhesion molecule (ICAM)-1 and E-selectin
(data not shown).
Preparation of microporous membranes and
cell seeding
For permeability determinations, two different culture
inserts were used, one containing a polyester (PE)
membrane (Transwell Clear) and the other containing
a collagen pre-treated polyethylene terephtalate
(PTFE) membrane (Transwell COL). Both types of
membrane contained 0.4mm diameter pores and a
growth area of 1 cm2. However, differences existed in
pore density and membrane thickness. While the PTFE
membranes were obtained with a collagen (bovine,
type I/III) coating in place, and thus were ready for
culturing, the PE membranes were prepared for cell
seeding by overnight incubation at room temperature
with either fibronectin (10mg/cm2 ), or gelatin
(10mg/cm2 ) in medium M199. No significant differ-
ence in permeability was observed between uncoated
and coated PE membranes (data not shown).
The inserts were placed in 12-well culture plates,
resulting in a two-compartment system separated by
the membrane. Approximately 105 cells/cm2 in 0.5 ml
of complete medium were seeded at the upper side of
the membrane, whereas 1.5 ml of complete medium
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was added to the lower compartment. These volumes
prevented hydrostatic fluid pressures across the
membranes. Both compartments were frequently
replenished with complete medium as described.
Cultures were grown for six days, resulting in the
formation of confluent monolayers, which was con-
firmed by phase contrast light microscopy.
In one experiment, the confluent cell layer was
selectively removed from the membranes. This was
achieved by briefly incubating the monolayers with a
25 mmol/l NH4OH solution. Removal of attaching
cells from the membrane was confirmed by transmis-
sion electron microscopy examination.
Transmission electron microscopy of HUVEC
monolayers
Cultured cells on Transwell inserts were washed twice
with serum-free medium prior to fixation with 2%
glutaraldehyde in phosphate-buffered saline (PBS).
After 60 min of fixation the Transwells were washed
with PBS and treated with 1% OsO4 for 30 min and
washed again with PBS. After several steps of dehydra-
tion, with 30%–70%–90%–100% alcohol, followed by
1:1 mix, 1:2 mix and pure epon 812, the membranes
were dissected from the Transwells with a small
diamond knife and flat embedded in pure epon 812.
Ultrathin sections were stained with uranyl acetate
and lead nitrate. The sections were examined with a
JEOL 1200 EX/II electron microscope (Tokyo, Japan)
at 60 kV.
TNF-a and LPS treatment
Dilutions of TNF-a (50, 500 pg/ml and 10 ng/ml) or
LPS (50,500 ng/ml and 10mg/ml) were prepared in
complete medium. In the LPS experiments, medium
containing 20% normal human serum was used
instead of heat-inactivated human and calf sera. At the
start of the experiment 0.5 ml of TNF-a- or LPS-
containing medium was added to the upper compart-
ment of the chamber. After overnight incubation at
37°C, the permeability of the monolayers was
determined.
Permeability studies
For the detection of macromolecular passage across
the membranes, a tracer solution containing both
FITC-labelled BSA (250mg/ml) and RITC-labelled dex-
tran (250mg/ml) was prepared in complete medium.
In the upper compartment, culture medium was
replaced by 0.5 ml of the tracer solution, while the
lower volume was refreshed with 1.5 ml complete
medium. After 1, 6 and 24 h of diffusion, 250ml
samples were drawn from the lower compartment,
which was replenished with an equal volume fresh
medium each time. The collected samples were
diluted with 1 ml PBS and the concentrations of FITC-
BSA and RITC-DEX were measured using a Hitachi
5000 fluorophotospectrometer, at emission/excita-
tion wavelengths of 495/520 nm and 560/580 nm,
respectively. The albumin and dextran concentrations
in the samples were calculated using linear regression
of a diluted series of the tracer.
Statistical analysis
Differences between permeability to albumin and
dextran were calculated by paired Student t-test. In
order to control for the different membrane types
used in our studies, the permeability of untreated
HUVEC monolayers was calculated as a ratio of the
corresponding unseeded membranes. Similarly, the
effect of treatment of monolayers on different mem-
branes was compared to control monolayers cultured
on corresponding membranes. Differences between
permeability ratios were calculated by Kruskall–
Wallis non-parametric ANOVA.
Results
Permeability of membranes with different
protein coatings and without seeded cells
Membranes coated with collagen, fibronectin or
gelatin showed significantly different permeability
rates. The diffusion of both albumin and dextran
occurred faster across the collagen-coated mem-
branes than across the fibronectin or gelatin-coated
membranes (Fig. 1). Permeability to albumin and
dextran appeared to be essentially the same,
although average dextran concentrations in the
lower compartment were almost invariably slightly
less than albumin concentrations. However, during
the permeability assay this difference never reached
statistical significance.
After 1 h of diffusion, the concentrations of albu-
min and dextran in the lower compartment of the
collagen-coated membrane inserts were 11.2 ±
4.5mg/ml and 10.1 ± 4.4mg/ml, respectively. This
accounted for approximately 17% of the calculated
equilibrium concentration of 62.5mg/ml. Significantly
less albumin and dextran accumulated in the lower
compartment of the gelatin- or fibronectin-coated
membranes, both allowing less than 2mg/ml during
the first hour, or about 5% of the calculated equilib-
rium concentration. At the end of the assay, after 24 h,
these differences were still significant, although less
explicit: the tracer concentration in the lower com-
partment of the collagen-coated membrane inserts
were 49.4 ± 4.3mg/ml (for albumin) and 46.4 ±
4.9mg/ml (for dextran), while less than 34mg/ml of
either molecule had accumulated in the lower com-
partment of the fibronectin or gelatin-coated mem-
brane inserts.
Endothelial permeability on different matrices
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Permeability of HUVEC monolayers
Culturing of HUVEC for six days resulted in the
growth of confluent monolayers that had formed
tight junctions throughout the culture. As shown in
Fig. 2, these junctions were present between cells
grown on all three different matrix proteins. On all
membranes the permeability to albumin and dex-
tran was significantly restricted by HUVEC mono-
layers (Fig. 3). Although monolayers cultured on
collagen-coated PTFE membranes allowed more
albumin and dextran passage than monolayers cul-
tured on gelatin-or fibronectin-coated PE mem-
branes, comparing the permeability to the corre-
sponding unseeded membranes showed that the
relative restriction to albumin and dextran by
HUVEC monolayers was similar for the three coat-
ings. For instance, after 1 h, monolayers cultured on
collagen, fibronectin or gelatin reduced passage of
albumin by 87.0 ± 4.8% (n = 12), 79.8 ± 5.6% (n =
4) or 82.2 ± 4.7% (n = 4), respectively, when
compared to the permeability of unseeded mem-
branes. After 24 h, these percentages were 55.5 ±
7.2, 61.7 ± 1.9 and 59.3 ± 8.2, respectively. Similar
data could be calculated for the dextran permeabil-
ity, but the relative restriction was not significantly
different between the three coatings.
In order to investigate whether the extracellular
matrix, produced by the cells during culture, differ-
ently contributed to the permeability after initial
seeding on either protein, HUVEC were grown for six
days and the permeability was measured. Thereafter,
the cells were lysed, leaving membranes with matrix
(coating plus the extracellular matrix laid down by
the cells) only and the permeability was measured
again. After cell lysis, albumin permeability measured
after 1 h of diffusion was increased by a factor 4.4 ±
0.8 (n = 4) on collagen-coated membranes, 4.9 ± 0.1
on fibronectin-coated membranes and 4.5 ± 0.1 on
gelatin-coated membranes. Dextran permeability
changed accordingly, but as with albumin, the perme-
ability increase after cell lysis did not significantly
differ between the collagen-, gelatin- and fibronectin-
coated membranes.
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FIG. 1. Permeability of Transwell culture inserts for FITC-
albumin and RITC-dextran. Bars represent the abluminal
concentration in mg/ml of permeated albumin (hatched bars)
and dextran (filled bars) after 1 (left panel), 6 (middle panel)
and 24 (right panel) h of equilibration. Data represent at least
four independent measurements originating from two or
more experiments and are expressed as mean ± SD. Culture
inserts: COL = collagen coated, FN = fibronectin coated, GEL
= gelatin coated.
FIG. 2. Ultramorphologic characteristics of HUVEC mono-
layers cultured on different matrices. HUVEC cultured on (A)
collagen- (B) fibronectin- and (C) gelatin-coated membranes.
Note junctional complexes between adjacent cells (arrow-
heads). Magnification 30,000´ .
Permeability of TNF-a or LPS-pretreated
HUVEC monolayers
Pre-incubation of the monolayers with increasing
doses of TNF-a or LPS resulted in a dose-dependent
increase in monolayer permeability. In order to allow
a quantitative comparison of the effects induced by
these inflammatory mediators on the monolayers
grown on the different coatings, permeability was
expressed as the ratio between treated and untreated
monolayers. While a dose of 50 pg/ml of TNF-a was
insufficient to enhance the permeability for albumin,
a dose of 500 pg/ml of TNF-a induced a moderate
permeability increase of the monolayers cultured on
collagen, fibronectin or gelatin (Fig. 4A). A further
stimulation was observed at a concentration of 10 ng/
ml TNF-a. After 1 h of diffusion, the relative increase
ranged from 2.0 ± 0.4 (on gelatin) to 2.3 ± 0.2 (on
collagen). The TNF-a effect could be observed on all
the coatings and no significant differences were
observed between monolayers cultured on either
collagen, gelatin or fibronectin. After 6 and 24 h of
diffusion, the permeability difference between TNF-a
treated monolayers and control monolayers gradually
declined, resulting in a ratio close to 1. Still, at the
highest dose the effect seemed persistent for at least
24 h: at this time the ratio between treated and non-
treated monolayers ranged between 1.2 ± 0.2 (on
collagen) to 1.3 ± 0.04 (on gelatin). A similar picture
emerged for the permeability to dextran (Fig. 4B).
Pre-incubation with bacterial LPS also induced a
dose-dependent increase in permeability which, like in
the TNF-a experiments, seemed qualitatively and
quantitatively independent of the protein on which
the monolayers were initially cultured. However, the
enhanced permeability seemed less persistent after
LPS pre-incubation than after pre-incubation with TNF-
a. After 1 h of diffusion, 500 ng/ml LPS had induced an
albumin permeability which was a factor 1.2 ± 0.2 (on
fibronectin) to 1.5 ± 0.3 (on collagen) higher than the
permeability in untreated monolayers (Fig. 5A). At
10mg/ml LPS a further increase was observed ranging
from a factor 1.9 ± 0.7 (on gelatin) to 2.3 ± 0.2 (on
collagen). Similar values were obtained from dextran
measurements (Fig. 5B). However, during further
incubation of albumin and dextran on LPS-treated
monolayers a rapid decline towards control monolayer
permeability was observed, reaching a ratio after 6 and
24 h that was not significantly different from 1.
Discussion
We have investigated the influence of different, but
commonly used, matrix protein substrates on the
permeability of resting, and TNF-a- or LPS-treated
HUVEC monolayers and found no essential differ-
ences between cells seeded on collagen, fibronectin
or gelatin.
Endothelial permeability on different matrices
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FIG. 3. Permeability of HUVEC monolayers cultured on
collagen, fibronectin and gelatin. Bars represent the ablumi-
nal concentration in mg/ml of permeated albumin (hatched
bars) and dextran (filled bars) in time (cf. legend to Fig. 1).
Data represent at least four independent measurements
originating from two or more experiments and are
expressed as mean ± SD.
FIG. 4. Permeability of TNF-a-treated HUVEC monolayers.
The increase in permeability to albumin (panel A) and
dextran (panel B) is expressed as the permeability ratio (±
SD, n = 4) between treated and untreated monolayers. In
panels, from left to right, the permeability ratio of mono-
layers cultured on collagen (COL), fibronectin (FN) and
gelatin (GEL), after 1, 6 and 24 h of diffusion is shown. Open
bars: 50 pg/ml TNF-a; grey bars: 500 pg/ml TNF-a; black bars:
10 ng/ml TNF-a.
One could think of several reasons for such a
difference to exist. The attachment and growth of
endothelial cells in vitro depends at least in part on
specific binding sites provided by the ECM. Also, the
ECM is involved in mechanisms by which inflamma-
tory mediators cause increased endothelial permea-
bility and loss of monolayer integrity. These receptor-
mediated mechanisms include: disruption of
cell–cell contacts by cytoskeletal and/or junctional
reorganization and alteration of endothelial adhesion
molecule expression,24 disruption of cell–matrix
contacts by altering endothelial matrix receptor
expression and loss of cell attachments sites in the
ECM;25 disruption of matrix–matrix contacts by
proteolytic degradation and remodelling of the
ECM.16 Despite the apparent contribution of ECM
proteins on endothelial permeability, different ECM
proteins, as well as mixtures of ECM proteins, have
been used for endothelial cell culturing.
For the evaluation of endothelial monolayer perme-
ability, multi-well culture inserts suited with micro-
porous membranes were used in this study. A major
advantage of these culture inserts is that they allow an
easy and multiple analysis of monolayer permeability,
with only minor modifications of the standard culture
conditions. Moreover, these inserts all allowed visual
examination of the monolayer before and after the
permeability assay. Across unseeded membranes, the
accumulation of albumin appeared always slightly
faster than that of dextran. Physical properties, like
shape, diameter and charge, of these molecules could
be responsible for this difference. Untreated cultured
HUVEC monolayers, and TNF-a- or LPS-treated mono-
layers, did not show a clear preference for the passage
of either albumin or dextran. Since albumin passage
occurs by both active vesicular and paracellular
transport, while dextran only passively diffuses
through the intercellular clefts,9,26 we conclude that
in our experiments diffusion via the transcellular
route contributes less to the permeability of resting
and activated monolayers and that the majority of
albumin and dextran pass the endothelial monolayer
by means of the paracellular route.
HUVEC monolayers cultured on collagen-, fibro-
nectin- or gelatin-coated membranes did not display
different morphologic characteristics, as was
revealed by light and transmission electron micros-
copy. All monolayers displayed typical cobblestone
morphology and tight junctions were abundantly
present between neighbouring cells. Confluence
was usually achieved within six days and was inde-
pendent of the type of coating used. In the permea-
bility experiments all differences observed between
the monolayers cultured on the three proteins could
be attributed to the original differences observed in
the unseeded filters. Thus, collagen, fibronectin and
gelatin are all suitable as a substrate for the attach-
ment and growth of endothelial cells in vitro, and in
our model, these substrates do not induce different
responses to inflammatory mediators. We assume
that additional ECM proteins, produced by the
endothelial cells and laid down into the ECM,
mediate most of the endothelial–ECM interactions
involved in monolayer permeability. The production
of ECM proteins, including fibronectin, laminin and
type IV collagen, by endothelial cells in vitro has
been previously shown by others.27 In our experi-
ments we did not see a difference in the membrane
permeability changes induced by a procedure which
removed the cells while leaving the ECM on the
membrane. Although the eventual composition of
the ECM may differ between monolayers cultured on
collagen, fibronectin and gelatin, its contribution to
the permeability of untreated and TNF-a or LPS-
HUVEC monolayers apparently is of minor signifi-
cance. When the monolayers were exposed to TNF-
a, a dose-dependent increase of permeability was
observed, which is in accordance with previous
observations.20 Although loss of fibronectin has been
associated with a TNF-a-mediated increase of perme-
ability,12 we did not observe a difference between
monolayers cultured on collagen-, fibronectin- or
gelatin-coated membranes. Possibly, in our experi-
ments TNF-a treatment did not induce significant
matrix degradation or matrix degradation equally
affected the three ECM proteins investigated.
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FIG. 5. Permeability of LPS-treated HUVEC monolayers. The
increase in permeability to albumin (panel A) and dextran
(panel B) is expressed as the permeability ratio (± SD, n = 4)
between treated and untreated monolayers. In panels, from
left to right, the permeability ratio of monolayers cultured on
collagen (COL), fibronectin (FN) and gelatin (GEL), after 1, 6
and 24 h of diffusion is shown. Open bars: 50 ng/ml LPS; grey
bars: 500 ng/ml LPS; black bars: 10mg/ml LPS.
When compared to TNF-a, LPS pre-treatment resul-
ted in a moderate and more transient increase of
permeability, suggesting that continuous exposure of
LPS may be required for a prolonged permeability
enhancement. Others have shown that the effect of
LPS on endothelial permeability depends on the
availability of soluble CD14 and lipopolysaccharide
binding protein in serum.28 Further studies are
needed to reveal eventual differences between TNF-a-
and LPS-induced endothelial permeability and the
reversibility of these changes.
In conclusion, we have demonstrated that cultured
HUVEC monolayers seeded on various proteins are
equally suitable as a model for vascular permeability,
showing physiologically relevant responses to inflam-
matory stimuli. Apparently, the initial differences in
cellular environment are unimportant with respect to
the eventual permeability characteristics of the con-
fluent monolayer, possibly as a result of additional
ECM laid down during culture.
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